financetom
Business
financetom
/
Business
/
Citigroup profit climbs on record revenue, while Mexico sale drags
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Citigroup profit climbs on record revenue, while Mexico sale drags
Oct 14, 2025 5:34 AM

Oct 14 (Reuters) - Citigroup ( C/PN ) reported a rise in

third-quarter profit, as all its divisions brought in record

revenue.

Citi and its competitors benefited from a resurgence in

activity in the third quarter as companies struck megadeals,

despite uncertainty over U.S. President Donald Trump's tariff

policies.

Net income in the reported quarter climbed 16% to $3.8

billion for Citi, compared with a year earlier, while earnings

per share jumped 23% to $1.86.

The surging profits came even after Citi booked a $726

million loss, which emerged from the sale of a 25% stake in its

Mexican subsidiary Banamex.

Revenue in Citi's banking unit gained 31.3% to $2.1 billion,

the biggest growth across its five divisions.

Global dealmaking surged in the first nine months of 2025,

driven by a strong increase in large transactions that pushed

investment banking toward historic peaks.

Megadeals in global mergers and acquisitions surged to $1.26

trillion in the third quarter, marking a 40% increase from the

same period last year.

Citi's markets revenue rose 16.7% to $5.6 billion in the

quarter, helped by a strong performance in fixed income.

A rate cut in September 2025, and hopes of further easing

this year, could help banks by spurring economic activity and

demand from borrowers.

Citi's return on tangible common equity stood at 8% in the

quarter and 8.6% so far this year, well short of the target set

by CEO Jane Fraser of 10% to 11% for next year.

Peers JPMorgan Chase ( JPM ) and Wells Fargo ( WFC ) also

reported higher third-quarter profits earlier on Tuesday, buoyed

by investment banking.

Citi's shares have gained 36.5% in 2025, compared with

increases of 28.5% for JPMorgan ( JPM ) and 12.4% for Wells Fargo ( WFC ). The

KBW banking index is up nearly 15% year to date.

MEXICO SALE

Citi announced last month that it would sell a 25% stake in

its retail unit Banamex to Mexican billionaire Fernando Chico

Pardo, chairman of airport operator ASUR, for around

$2.3 billion. The sale triggered a $726 million goodwill

impairment that reduced the lender's third-quarter earnings.

The bank had planned to hold a public offering for the rest

of the unit, it said at the time. However, in a surprise move,

Mexican mining and transport conglomerate Grupo Mexico

made an unsolicited $9.3 billion offer for

Banamex.

Citi rejected the offer last week.

The bank bought Banamex in a $12.5 billion deal in 2001. CEO

Fraser decided to sell it as she divested overseas businesses,

but Citi struggled to find a buyer after talks with Grupo Mexico

fell through in 2023.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
NewMarket Sets New $500 Million Share Buyback Plan
NewMarket Sets New $500 Million Share Buyback Plan
Dec 12, 2024
05:35 PM EST, 12/12/2024 (MT Newswires) -- NewMarket (NEU) said late Thursday it received board approval for a new share repurchase program for up to $500 million of its common stock. The new program runs until Dec. 31, 2027, and replaces the current $500 million program expiring at the end of this year. The company said it may buy shares...
Pinnacle West Capital CEO Jeff Guldner to Retire; Ted Geisler to Take Over
Pinnacle West Capital CEO Jeff Guldner to Retire; Ted Geisler to Take Over
Dec 12, 2024
05:45 PM EST, 12/12/2024 (MT Newswires) -- Pinnacle West Capital ( PNW ) said late Thursday that the chairman and chief executive of the company and Arizona Public Service, Jeff Guldner, will retire on March 31. Ted Geisler will become chairman, president and CEO of Pinnacle West and Arizona Public Service, effective April 1, the company said. Guldner will continue...
Editas Medicine Focuses on In Vivo Gene-Editing Medicines, Ends Reni-Cel Development to Cut Costs
Editas Medicine Focuses on In Vivo Gene-Editing Medicines, Ends Reni-Cel Development to Cut Costs
Dec 12, 2024
05:35 PM EST, 12/12/2024 (MT Newswires) -- Editas Medicine ( EDIT ) said late Thursday that it will focus on in vivo CRISPR-edited medicines and end the development of reni-cel to optimize cost structure and extend cash runway into Q2 2027. The strategic transition will help the company accelerate in vivo human proof of concept in about two years, the...
Boundless Bio Chief Medical Officer, Chief Business Officer to Step Down in December, January
Boundless Bio Chief Medical Officer, Chief Business Officer to Step Down in December, January
Dec 12, 2024
05:38 PM EST, 12/12/2024 (MT Newswires) -- Boundless Bio ( BOLD ) said its Chief Medical Officer Klaus Wagner and Chief Business Officer Neil Abdollahian will leave the company at the end of December and early January, respectively. James Freddo, currently a company advisor with almost 30 years of clinical leadership experience, will serve as interim CMO while Boundless Bio...
Copyright 2023-2026 - www.financetom.com All Rights Reserved